Evidence map›Paper›PMID 37089868›Full record

ArticleDrug and alcohol dependence reports2023

"

C J Valasek, Samantha A Streuli, Heather A Pines, Steffanie A Strathdee, Annick Borquez, Philippe Bourgois, Tara Stamos-Buesig, Carlos F Vera, Alicia Harvey-Vera, Angela R Bazzi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Drug and alcohol dependence reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Routes of Drug Use Among Drug Overdose Deaths - United States, 2020-2022.MMWR. Morbidity and mortality weekly report · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

C J ValasekAssociate Professor, Herbert Wertheim School of Public Health, University of California San Diego, 9500 Gilman Drive, MTF 265E (Mail Code 0725), La Jolla, San Diego, CA 92161, USA.
Samantha A StreuliAssociate Professor, Herbert Wertheim School of Public Health, University of California San Diego, 9500 Gilman Drive, MTF 265E (Mail Code 0725), La Jolla, San Diego, CA 92161, USA.
Heather A PinesAssociate Professor, Herbert Wertheim School of Public Health, University of California San Diego, 9500 Gilman Drive, MTF 265E (Mail Code 0725), La Jolla, San Diego, CA 92161, USA.
Steffanie A StrathdeeSchool of Medicine, University of California, San Diego, San Diego, CA, USA.
Annick BorquezSchool of Medicine, University of California, San Diego, San Diego, CA, USA.
Philippe BourgoisUCLA Semel Institute, University of California Los Angeles Center for Social Medicine, B7-435, Los Angeles, CA, USA.
Tara Stamos-BuesigOnPoint, Harm Reduction Coalition of San Diego, San Diego, CA, USA.
Carlos F VeraSchool of Medicine, University of California, San Diego, San Diego, CA, USA.
Alicia Harvey-VeraSchool of Medicine, University of California, San Diego, San Diego, CA, USA.
Angela R BazziAssociate Professor, Herbert Wertheim School of Public Health, University of California San Diego, 9500 Gilman Drive, MTF 265E (Mail Code 0725), La Jolla, San Diego, CA 92161, USA.
University of California San Diego · USBoston University · USHarm Reduction Services · USSan Diego State University · USUniversity of California, Los Angeles · US

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 1994 to 2026
$78.4M
Real-time prediction of emerging drug use epidemics in the United StatesDP2DA049295 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BORQUEZ, ANNICK · 2019 to 2019
$2.4M
NCATS NIH HHS UL1 TR001442NIAID NIH HHS P30 AI036214NIDA NIH HHS DP2 DA049295
6 · The paper itself

Abstract

Background: People who use drugs (PWUD) in the San Diego, USA and Tijuana, Mexico metroplex face high overdose risk related to historic methamphetamine use and relatively recent fentanyl introduction into local drug supplies. The personal overdose experiences of PWUD in this region are understudied, however, and may have been influenced by the COVID pandemic. Methods: From September-November 2021, we conducted 28 qualitative interviews among PWUD ≥18 years old sampled from an ongoing cohort study in the San Diego-Tijuana metroplex. Interviews explored overdose experiences and changes in the drug supply. Thematic analysis of coded interview transcripts explored overdose experiences, perspectives on drug supply changes, interactions with harm reduction services, and naloxone access. Results: Among 28 participants, 13 had experienced an overdose. Participants discussed rising levels of fentanyl in local drug supplies and increasing overdose incidents in their social networks. Participants discussed a general shift from injecting heroin to smoking fentanyl in their networks. Participants' most common concerns included having consistent access to a safe and potent drug supply and naloxone. Conclusion: Participants prioritized adapting to drug supply changes and preventing overdose compared to other health concerns, such as HIV and COVID-19. Efforts to address overdose in this region could benefit from drug checking services and expanded, equitable delivery of naloxone.

Indexed as

COVID-19 PandemicDrug overdoseFentanylNaloxonePeople who use drugs

Identifiers

PMID37089868
PMCPMC10113744
OpenAlexW4361223856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.